The company, along with other medical device makers, have been hit with series of lawsuits related to transvaginal meshes, intended to treat pelvic organ prolapse. Last July, Endo settled a batch of product liability lawsuits brought against subsidiary American Medical Systems Holdings over its pelvic mesh implants.
The FDA, prompted by a significant increase in complaints about a type of surgical mesh used to treat pelvic organ prolapse in women, put the products under its most stringent level of review, Class III, in January.
CL Medical with their I-STOP female incontinence mesh supported by strong clinical evidence, is proving, not only the efficiency of the product, but also its quality. With this product of such high standard, the manufacturer is positioned to take advantage in the market. Indeed, with several players removing themselves from the market, CL Medical could become a dominant player in the incontinence field.
LOK Corporation is proud to be their partner as international manufacturer agent.
For more information on the products and explore the opportunity for your market, please contact our manufacturer agent department at clmedical@lok-corporation.com